z-logo
Premium
B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin‐resistant cell line
Author(s) -
Zhou Huimin,
Zhang Zhaohai,
Liu Chunqing,
Jin Changgong,
Zhang Jianing,
Miao Xiaoyan,
Jia Li
Publication year - 2012
Publication title -
iubmb life
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.132
H-Index - 113
eISSN - 1521-6551
pISSN - 1521-6543
DOI - 10.1002/iub.1080
Subject(s) - k562 cells , biology , cell culture , rna interference , p glycoprotein , gene knockdown , cancer research , leukemia , multiple drug resistance , microbiology and biotechnology , gene , drug resistance , immunology , biochemistry , rna , genetics
Abstract B4GALT1 gene encodes type II membrane‐bound glycoprotein, named β‐1, 4‐galactosyltransferase 1 (β1, 4‐Gal‐T1), which can transfer galactose to acceptor sugars. B4GALT1 gene plays important roles in physiological process and disease development. In this study, we investigate the possible role and mechanism of B4GALT1 gene in multidrug resistance of human leukemia cell line. Significantly, higher expression of B4GALT1 was observed in adriamycin‐resistant (ADR) K562 cell line (K562/ADR) than that in K562 cell line by real‐time polymerase chain reaction and Western blotting. The activity of β1, 4‐Gal‐T1 enzyme, and Galβ‐1,4GlcNAc structures on cell membrane glycoproteins was found at higher levels in K562/ADR cells than those in K562 cells. Further analysis of the B4GALT1 deregulation after using RNA interference approach showed that the silencing of B4GALT1 in K562/ADR cells resulted in increased sensitivity to chemotherapeutic drugs both in vitro and in vivo. The activity of the hedgehog signaling pathway affected the chemosensitivity of K562/ADR cells and was downregulated in K562/ADR cells with suppression of B4GALT1 gene. We hypothesize that B4GALT1 is responsible for the overcoming multidrug resistance in human leukemia therapy via regulating the activity of the hedgehog signaling pathway. © 2012 IUBMB, IUBMB Life, 64(11): 889–900, 2012

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here